| Literature DB >> 29128811 |
Marzena Ułamek-Kozioł1, Janusz Kocki2, Anna Bogucka-Kocka3, Sławomir Januszewski4, Jacek Bogucki2, Stanisław J Czuczwar5, Ryszard Pluta6.
1. First Department of Neurology, Institute of Psychiatry and Neurology, Warszawa, Poland; Laboratory of Ischemic and Neurodegenerative Brain Research, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warszawa, Poland.
2. Department of Clinical Genetics, Medical University of Lublin, Lublin, Poland.
3. Department of Biology and Genetics, Medical University of Lublin, Lublin, Poland.
4. Laboratory of Ischemic and Neurodegenerative Brain Research, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warszawa, Poland.
5. Department of Pathophysiology, Medical University of Lublin, Lublin, Poland; Department of Physiopathology, Institute of Rural Health, Lublin, Poland. Electronic address: czuczwarsj@yahoo.com.
6. Laboratory of Ischemic and Neurodegenerative Brain Research, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warszawa, Poland. Electronic address: pluta@imdik.pan.pl.
Abstract
Entities:
Keywords: Alzheimer’s disease; Brain ischemia; Delayed neuronal death; Genes; Hippocampal CA1 area
Mesh:
Alzheimer Disease/genetics
Alzheimer Disease/physiopathology
Animals
Apoptosis/genetics
Autophagy/genetics
Brain Ischemia/physiopathology
CA1 Region, Hippocampal/physiopathology
Caspase 3/genetics
Disease Models, Animal
Female
Mitophagy/genetics
Rats
Rats, Wistar
Reverse Transcriptase Polymerase Chain Reaction
Time Factors
Up-Regulation
Substances:
Caspase 3
Year: 2017 PMID: 29128811 DOI: 10.1016/j.pharep.2017.07.015
Source DB: PubMed Journal: Pharmacol Rep ISSN: 1734-1140 Impact factor: 3.024